Improved Outcome Prediction for Appendiceal Pseudomyxoma Peritonei by Integration of Cancer Cell and Stromal Transcriptional Profiles
In recent years, cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) have substantially improved the clinical outcome of pseudomyxoma peritonei (PMP) originating from mucinous appendiceal cancer. However, current histopathological grading of appendiceal PMP frequently f...
Main Authors: | Claudio Isella, Marco Vaira, Manuela Robella, Sara Erika Bellomo, Gabriele Picco, Alice Borsano, Andrea Mignone, Consalvo Petti, Roberta Porporato, Alexandra Ambra Ulla, Alberto Pisacane, Anna Sapino, Michele De Simone, Enzo Medico |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-06-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/12/6/1495 |
Similar Items
-
A case of Pseudomyxoma Peritonei of an unexpected origin
by: Marie Csanyi-Bastien, et al.
Published: (2021-12-01) -
A case of Endometrioid endometrial adenocarcinoma with synchronous low-grade Appendiceal mucinous neoplasm and Pseudomyxoma peritonei
by: Shweta Raje, et al.
Published: (2021-01-01) -
Pseudomyxoma Peritonei in a Patient with History of Breast Cancer
by: Tae Seob Jung, et al.
Published: (2016-03-01) -
Pseudomyxoma peritonei of appendiceal origin mimicking ovarian cancer –
a case report with literature review
by: Stoyan Kostov, et al.
Published: (2021-09-01) -
Germline whole exome sequencing of a family with appendiceal mucinous tumours presenting with pseudomyxoma peritonei
by: Mei Sim Lung, et al.
Published: (2020-05-01)